Cresset Asset Management, LLC Blueprint Medicines Corp Transaction History
Cresset Asset Management, LLC
- $19.6 Billion
- Q2 2025
Shares
2 transactions
Others Institutions Holding BPMC
# of Institutions
287Shares Held
53.9MCall Options Held
950KPut Options Held
1.52M-
Black Rock Inc. New York, NY6.65MShares$861 Million0.02% of portfolio
-
Pentwater Capital Management LP Naples, FL3.9MShares$505 Million3.34% of portfolio
-
State Street Corp Boston, MA2.23MShares$289 Million0.01% of portfolio
-
Ubs Group Ag2.17MShares$281 Million0.05% of portfolio
-
Fil LTD Hamilton, D01.76MShares$228 Million0.21% of portfolio
About Blueprint Medicines Corp
- Ticker BPMC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,719,600
- Market Cap $7.73B
- Description
- Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...